Accumulated Other Comprehensive Income (Tables)

6 Months Ended

Jun. 30, 2025

AOCI represents cumulative gains and losses that are not reflected in earnings. AOCI balances and the components of other comprehensive income (loss) are as follows:


	Total AOCI
Balance at March 31, 2024	$	(17,576)
Available for sale securities:
Net unrealized gain (loss), net of tax expense (benefit) of $51	183
Other reclassifications included in other revenue, net of tax expense (benefit) of $3	7
Held to maturity securities:
Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $131	452
Other (1)	(2)
Balance at June 30, 2024	$	(16,936)

Balance at March 31, 2025	$	(13,621)
Available for sale securities:
Net unrealized gain (loss), net of tax expense (benefit) of $116	501
Other reclassifications included in other revenue, net of tax expense (benefit) of $8	22
Held to maturity securities:
Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $61	500
Derivatives designated as cash flow hedging instruments:
Net unrealized gain (loss), net of tax expense (benefit) of $(4)	(11)
Reclassifications included in interest revenue, net of tax expense (benefit) of $4	13
Other (1)	5
Balance at June 30, 2025	$	(12,591)

Balance at December 31, 2023	$	(18,131)
Available for sale securities:
Net unrealized gain (loss), net of tax expense (benefit) of $77	296

Other reclassifications included in other revenue, net of tax expense (benefit) of $5	15
Held to maturity securities:

Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $253	894
Other (1)	(10)
Balance at June 30, 2024	$	(16,936)

Balance at December 31, 2024	$	(14,848)
Available for sale securities:
Net unrealized gain (loss), net of tax expense (benefit) of $369	1,309

Other reclassifications included in other revenue, net of tax expense (benefit) of $10	30
Held to maturity securities:

Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $189	910
Derivatives designated as cash flow hedging instruments:
Net unrealized gain (loss), net of tax expense (benefit) of $(4)	(11)
Reclassifications included in interest revenue, net of tax expense (benefit) of $4	13
Other (1)	6
Balance at June 30, 2025	$	(12,591)

(1) Tax expense (benefit) was less than $500 thousand.